Stock Analiz

4D Molecular Therapeutics, Inc. (FDMT) stock forecast and price target

Price $12.23 · data as of November 13, 2026

12-month price target

Average target$28.09
Upside / downside+129.7%
Analysts11
ConsensusStrong buy
Low $18.00Average $28.09High $37.00

Gold marker: average target · white marker: today’s price ($12.23)

Analyst ratings

Strong buy 2Buy 9Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-4.16−72.0%$13M
Next fiscal year
ends December 31, 2027
$-4.19−0.7%$17M
Next quarter
ends December 31, 2026
$-1.04−341.6%$3M
Quarter after
ends March 31, 2027
$-1.12−11.4%$2M

Consensus of the analysts covering 4D Molecular Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the 4D Molecular Therapeutics stock price target?

The average 12-month target from 11 analysts is $28.09, 129.7% above the current price of $12.23 Targets range from $18.00 to $37.00.

Is 4D Molecular Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 9 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is 4D Molecular Therapeutics expected to earn?

Analysts expect EPS of $-4.16 for the fiscal year ending December 31, 2026 and $-4.19 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.